New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the

Overview

Journal J Cardiovasc Dev Dis

Specialty Cardiology & Vascular Diseases

Date 2023 Feb 24

PMID 36826557

Authors

Giuseppe Boriani

Niccolo Bonini

Jacopo Francesco Imberti

Marco Vitolo

Affiliations

Soon will be listed here.

Abstract

The medical approach to atrial fibrillation (AF) underwent a paradigm shift over time, evolving from considering AF as a simple arrhythmic phenomenon to a complex nosological entity [...].

References

Guenancia C, Hammache N, Docq C, Benali K, Hooks D, Echivard M . Efficacy and Safety of Second and Third-Generation Laser Balloon for Paroxysmal Atrial Fibrillation Ablation Compared to Radiofrequency Ablation: A Matched-Cohort. J Cardiovasc Dev Dis. 2021; 8(12). PMC: 8704020. DOI: 10.3390/jcdd8120183. View

Di Monaco A, Vitulano N, Troisi F, Quadrini F, Romanazzi I, Calvi V . Pulsed Field Ablation to Treat Atrial Fibrillation: A Review of the Literature. J Cardiovasc Dev Dis. 2022; 9(4). PMC: 9030965. DOI: 10.3390/jcdd9040094. View

Imberti J, Ding W, Kotalczyk A, Zhang J, Boriani G, Lip G . Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021; 107(20):1630-1636. DOI: 10.1136/heartjnl-2021-319496. View

Baena-Montes J, OHalloran T, Clarke C, Donaghey K, Dunne E, OHalloran M . Electroporation Parameters for Human Cardiomyocyte Ablation In Vitro. J Cardiovasc Dev Dis. 2022; 9(8). PMC: 9409892. DOI: 10.3390/jcdd9080240. View

Gauvrit S, Bossaer J, Lee J, Collins M . Modeling Human Cardiac Arrhythmias: Insights from Zebrafish. J Cardiovasc Dev Dis. 2022; 9(1). PMC: 8779270. DOI: 10.3390/jcdd9010013. View

Vitolo M, Imberti J, Proietti M, Lip G, Boriani G . Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply. Eur J Intern Med. 2022; 98:115-116. DOI: 10.1016/j.ejim.2022.01.032. View

Cepas-Guillen P, Flores-Umanzor E, Regueiro A, Brugaletta S, Ibanez C, Sanchis L . Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion. J Cardiovasc Dev Dis. 2021; 8(11). PMC: 8623304. DOI: 10.3390/jcdd8110142. View

Romiti G, Proietti M, Vitolo M, Bonini N, Fawzy A, Ding W . Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry. BMC Med. 2022; 20(1):326. PMC: 9440492. DOI: 10.1186/s12916-022-02526-7. View

Boriani G, Vitolo M, Diemberger I, Proietti M, Valenti A, Malavasi V . Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc Res. 2021; 117(7):1-21. PMC: 8707734. DOI: 10.1093/cvr/cvab147. View

10.

Gue Y, Bisson A, Bodin A, Herbert J, Lip G, Fauchier L . Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study. J Cardiovasc Dev Dis. 2021; 8(12). PMC: 8707232. DOI: 10.3390/jcdd8120177. View

11.

Vitolo M, Proietti M, Harrison S, Lane D, Potpara T, Boriani G . The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years. Intern Emerg Med. 2020; 15(7):1183-1192. DOI: 10.1007/s11739-020-02405-0. View

12.

Wang J, Chen Z, Yang H, Li H, Chen R, Yu J . Relationship between the Hemoglobin-to-Red Cell Distribution Width Ratio and All-Cause Mortality in Septic Patients with Atrial Fibrillation: Based on Propensity Score Matching Method. J Cardiovasc Dev Dis. 2022; 9(11). PMC: 9696521. DOI: 10.3390/jcdd9110400. View

13.

Rivaud M, Blok M, Jongbloed M, Boukens B . How Cardiac Embryology Translates into Clinical Arrhythmias. J Cardiovasc Dev Dis. 2021; 8(6). PMC: 8231901. DOI: 10.3390/jcdd8060070. View

14.

Ding W, Proietti M, Romiti G, Vitolo M, Fawzy A, Boriani G . Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry. Eur J Intern Med. 2022; 107:60-65. DOI: 10.1016/j.ejim.2022.11.004. View

15.

Boriani G, Svennberg E, Guerra F, Linz D, Casado-Arroyo R, Malaczynska-Rajpold K . Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey. Europace. 2022; 24(11):1834-1843. DOI: 10.1093/europace/euac142. View

16.

Deb B, Ganesan P, Feng R, Narayan S . Identifying Atrial Fibrillation Mechanisms for Personalized Medicine. J Clin Med. 2021; 10(23). PMC: 8658178. DOI: 10.3390/jcm10235679. View

17.

Li X, Bao Y, Jia K, Zhang N, Lin C, Wei Y . Comparison of the Mid-Term Outcomes of Robotic Magnetic Navigation-Guided Radiofrequency Ablation versus Cryoballoon Ablation for Persistent Atrial Fibrillation. J Cardiovasc Dev Dis. 2022; 9(3). PMC: 8953767. DOI: 10.3390/jcdd9030088. View

18.

Friedman D, Holmes D, Curtis A, Ellenbogen K, Frankel D, Knight B . Procedure characteristics and outcomes of atrial fibrillation ablation procedures using cryoballoon versus radiofrequency ablation: A report from the GWTG-AFIB registry. J Cardiovasc Electrophysiol. 2020; 32(2):248-259. DOI: 10.1111/jce.14858. View

19.

Chen S, Chun K, Ling Z, Liu S, Zhu L, Wang J . Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update. J Cardiovasc Dev Dis. 2021; 8(6). PMC: 8230807. DOI: 10.3390/jcdd8060069. View

20.

Giannone M, Filippini T, Whelton P, Chiari A, Vitolo M, Boriani G . Atrial Fibrillation and the Risk of Early-Onset Dementia: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2022; 11(14):e025653. PMC: 9707836. DOI: 10.1161/JAHA.122.025653. View